In breast cancer, thepresence of HMGA2 mRNA in blood and high expressionin tumours are associated with poor prognosis, late stage,and increased metastasis risk(Langelotz et al., 2003; Wu etal., 2016). This evidence concerns the gene HMGA2 and neoplasm.